- Report
- February 2026
- 250 Pages
Global
From €4034EUR$4,490USD£3,515GBP
- Report
- February 2026
- 250 Pages
Global
From €4034EUR$4,490USD£3,515GBP
- Report
- January 2026
- 185 Pages
Global
From €4043EUR$4,500USD£3,523GBP
- Report
- January 2026
- 180 Pages
Global
From €4043EUR$4,500USD£3,523GBP
- Report
- June 2025
- 150 Pages
Global
From €2425EUR$2,699USD£2,113GBP
- Report
- June 2025
- 200 Pages
Global
From €2506EUR$2,789USD£2,183GBP
- Report
- February 2026
- 160 Pages
Global
From €2983EUR$3,320USD£2,599GBP
€3728EUR$4,150USD£3,249GBP
- Report
- August 2025
- 150 Pages
Global
From €4357EUR$4,850USD£3,797GBP
- Report
- July 2025
- 150 Pages
Global
From €4357EUR$4,850USD£3,797GBP
- Report
- May 2025
- 134 Pages
Global
From €16167EUR$17,995USD£14,088GBP
- Report
- August 2025
- 98 Pages
Global
From €4357EUR$4,850USD£3,797GBP
- Report
- April 2026
- 50 Pages
Global
From €2381EUR$2,650USD£2,075GBP
- Report
- April 2026
- 50 Pages
Global
From €2381EUR$2,650USD£2,075GBP
- Report
- April 2026
- 50 Pages
Global
From €2381EUR$2,650USD£2,075GBP
- Report
- April 2026
- 50 Pages
Global
From €2381EUR$2,650USD£2,075GBP
- Report
- April 2026
- 50 Pages
Global
From €2381EUR$2,650USD£2,075GBP
- Report
- January 2026
Global
From €6738EUR$7,500USD£5,872GBP
- Report
- July 2024
- 288 Pages
Global
From €5167EUR$5,952USD£4,350GBP
- Report
- November 2022
- 353 Pages
Global
From €4692EUR$5,405USD£3,950GBP
- Report
- February 2025
- 274 Pages
Global
From €4447EUR$4,950USD£3,875GBP

The HIV/AIDS Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs to treat HIV/AIDS. These drugs are used to treat the virus itself, as well as the symptoms and complications associated with it. HIV/AIDS drugs are typically divided into two categories: antiretroviral drugs, which are used to suppress the virus, and prophylactic drugs, which are used to prevent the transmission of the virus.
The HIV/AIDS Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Gilead Sciences, Merck, GlaxoSmithKline, Bristol-Myers Squibb, and Pfizer. These companies are constantly developing new drugs and treatments to improve the quality of life for those living with HIV/AIDS. Show Less Read more